Company profile
ENDONOVO THERAPEUTICS, INC. CIK 1528172
Ticker
ENDV (OTC)
Industry
Electromedical & Electrotherapeutic Apparatus
Headquarters
Woodland Hills, CA 91367
Fiscal year end
2022 (FY)
Key Financials
Revenue
$135.4K
Net income
-$18.47M
Total assets
$1.28M
Total liabilities
$33.46M
Stockholders' equity
-$32.18M
Cash & equivalents
—
Operating income
-$3.26M
Operating cash flow
-$678.8K
Capital expenditures
—
Fiscal year 2022, via 10-K filed 2023-04-17. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-2,411.7%
Net margin
-13,649.2%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
2,611.6%
Equity / assets
-2,511.6%
CapEx / revenue
—
Operating cash flow / net income
0.04×
Derived from the fiscal year 2022 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2022
$135.4K
-$18.47M
$1.28M
$33.46M
-$32.18M
2021
$73.1K
-$3.10M
$2.01M
$17.78M
-$15.77M
2020
$165.8K
-$395.6K
$2.61M
$16.98M
-$14.37M
2019
$310.2K
-$17.31M
$3.27M
$23.78M
-$20.50M
2018
$83.3K
-$6.44M
$4.24M
$15.63M
-$11.39M
Company Details
SIC code
3845
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form SEC STAFF ACTION
2024-09-19
Financials filed via
Form 10-K
filed 2023-04-17
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Woodland Hills, CA 91367
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:17 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.